Treatment of primary liver graft non-function with prostaglandin E1 results in increased graft and patient survival.
Greig
P D
PD
Liver Transplant Program, University of Toronto, Ontario, Canada.
Woolf
G M
GM
Abecassis
M
M
Strasberg
S M
SM
Taylor
B
B
Superina
R A
RA
Langer
B
B
Glynn
M F
MF
Ettles
M
M
Blendis
L
L
D000328:Adult; D000527:Alprostadil / Q000008:administration & dosage / Q000627:therapeutic use*; D001219:Aspartate Aminotransferases / Q000097:blood; D001777:Blood Coagulation / Q000187:drug effects; D002405:Catheterization, Central Venous; D002675:Child, Preschool; D005260:Female; D005500:Follow-Up Studies; D006085:Graft Survival / Q000187:drug effects*; D006801:Humans; D007262:Infusions, Intravenous; D008099:Liver / Q000187:drug effects / Q000503:physiopathology; D016031:Liver Transplantation; D008297:Male; D008875:Middle Aged; D011379:Prognosis
D001219:Aspartate Aminotransferases; D000527:Alprostadil